Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tissue Renewal without Stem Cells01:23

Tissue Renewal without Stem Cells

1.8K
After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
1.8K
Tissue Transplantation01:24

Tissue Transplantation

562
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
562
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.2K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.2K
T Cell Types and Functions01:24

T Cell Types and Functions

1.5K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.5K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

75.0K
Overview
75.0K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

7.7K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
7.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The neural correlates of movement imagery performance in Parkinson's disease: Evidence of impairment and compensation.

Human movement science·2026
Same author

Arousal state modulates human hippocampal ripples.

bioRxiv : the preprint server for biology·2026
Same author

Armored chimeric antigen receptor T-cell therapy targets antigen-heterogeneous glioma.

Cancer research·2026
Same author

Engineering CAR T cells to secrete VEGF-neutralizing scFvs enhances antitumor activity against solid tumors.

Science translational medicine·2026
Same author

What do you most hope we will achieve with mammalian synthetic biology within the next decade?

Cell systems·2025
Same author

Overcoming solid-tumor barriers: armored CAR-T cell therapy.

Trends in cancer·2025

Related Experiment Video

Updated: Oct 7, 2025

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
07:50

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Published on: September 3, 2020

4.7K

T cells to fix a broken heart.

Torahito A Gao1, Yvonne Y Chen1,2,3

  • 1Department of Chemical and Biomolecular Engineering, University of California, Los Angeles (UCLA), Los Angeles, CA, USA.

Science (New York, N.Y.)
|January 6, 2022
PubMed
Summary

Engineered T cells show potential for treating heart disease. This innovative therapy offers a new avenue for cardiac repair and regeneration.

More Related Videos

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells
12:46

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells

Published on: August 17, 2022

2.7K
Murine Heterotopic Heart Transplant Technique
10:27

Murine Heterotopic Heart Transplant Technique

Published on: July 8, 2014

17.3K

Related Experiment Videos

Last Updated: Oct 7, 2025

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
07:50

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Published on: September 3, 2020

4.7K
Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells
12:46

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells

Published on: August 17, 2022

2.7K
Murine Heterotopic Heart Transplant Technique
10:27

Murine Heterotopic Heart Transplant Technique

Published on: July 8, 2014

17.3K

Area of Science:

  • Immunology
  • Cardiology
  • Regenerative Medicine

Background:

  • Cardiac diseases represent a significant global health burden.
  • Current treatments for cardiac conditions have limitations.
  • Cellular therapies are emerging as a promising alternative.

Purpose of the Study:

  • To explore the therapeutic potential of in vivo engineered T cells for cardiac diseases.
  • To evaluate the efficacy and safety of this novel approach.

Main Methods:

  • Genetic engineering of T cells for targeted delivery to the heart.
  • In vivo administration of engineered T cells in preclinical models of cardiac injury.
  • Assessment of cardiac function, tissue repair, and immune response.

Main Results:

  • Engineered T cells demonstrated significant improvement in cardiac function.
  • Evidence of reduced inflammation and enhanced myocardial regeneration was observed.
  • The treatment was well-tolerated with no major adverse effects.

Conclusions:

  • In vivo engineered T cells represent a viable and promising therapeutic strategy for cardiac diseases.
  • This approach holds potential for advancing regenerative cardiology.
  • Further research is warranted to translate these findings to clinical practice.